Rani Therapeutics Holdings, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RANI Nasdaq 2836 www.ranitherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rani Therapeutics Holdings, Inc.

Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen - Jan 8th, 2026 5:00 am
Rani Therapeutics to Participate in the Evercore Healthcare Conference - Nov 24th, 2025 2:05 pm
RANI: Third Quarter Results - Nov 10th, 2025 10:45 am
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update - Nov 6th, 2025 2:30 pm
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - Oct 30th, 2025 6:00 am
H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential - Oct 26th, 2025 4:05 am
Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors - Oct 23rd, 2025 2:05 pm
Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules - Oct 23rd, 2025 2:01 pm
RANI: Chugai Deal Announced - Oct 20th, 2025 9:06 am
Trending tickers: Apple, Beyond Meat, Rani Therapeutics, BitMine and B&M - Oct 20th, 2025 4:53 am
Rani Therapeutics (RANI): Examining Valuation After Landmark Chugai Deal and $60M Funding Boost - Oct 19th, 2025 9:10 pm
Rani Therapeutics (RANI) Is Up 257.9% After $1.08 Billion Chugai Deal and $60M Fundraise—What’s Changed - Oct 18th, 2025 12:07 pm
Top Midday Gainers - Oct 17th, 2025 11:58 am
Why Rani Therapeutics (RANI) Stock Is Soaring Friday? - Oct 17th, 2025 11:12 am
Rani Therapeutics Enters Into Up to $1.09 Billion Collaboration, License Deal With Chugai Pharmaceutical -- Shares Rise Premarket - Oct 17th, 2025 6:31 am
Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules - Oct 17th, 2025 5:31 am
Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing - Oct 17th, 2025 5:30 am
RANI: Second Quarter Financial Results - Aug 12th, 2025 4:49 am
Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update - Aug 7th, 2025 2:05 pm
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering - Jul 15th, 2025 7:00 am